Reuters India Business

India’s Samvardhana Motherson quarterly profit beats views as revenue rises across units

13 Nov 2025

(Reuters) -Indian auto-parts maker Samvardhana Motherson posted a smaller-than-expected drop in second-quarter profit on Thursday, as revenue rose across all segments, with its emerging businesses unit recording the biggest increase. Its consolidated net profit fell 6% to 8.27 billion rupees ($94.09 million) in the three months ended September 30, above analysts’ estimate of profit falling …

India’s Samvardhana Motherson quarterly profit beats views as revenue rises across units Read More »

India arrests Jaypee Infratech ex-chairman in funds diversion probe

13 Nov 2025

By Nikunj Ohri NEW DELHI (Reuters) -India’s financial crime fighting agency said on Thursday it has arrested the former chairman of real estate company Jaypee Infratech, Manoj Gaur, for alleged diversion of funds collected from home buyers. The company’s real estate projects included residential townships in the northern city of Noida, and developing the Yamuna …

India arrests Jaypee Infratech ex-chairman in funds diversion probe Read More »

Indian shares stall as rally peters out before Bihar election results

13 Nov 2025

By Bharath Rajeswaran (Reuters) -Indian equities ended flat on Thursday, as gains in metal stocks and upbeat earnings were offset by caution ahead of Bihar’s state election results, seen as key for policy continuity. The Nifty 50 inched 0.01% higher to 25,879.15, and the BSE Sensex added 0.01% to 84,478.67. The benchmark indexes have advanced …

Indian shares stall as rally peters out before Bihar election results Read More »

Indian mutual funds pivot to ultra-short debt as rate outlook clouds bets

13 Nov 2025

By Dharamraj Dhutia MUMBAI (Reuters) -India’s mutual funds will stick with ultra-short-term bonds as an uncertain interest rate outlook and global trade concerns curb appetite for long-tenor securities, fund managers said. The Reserve Bank of India’s next monetary policy decision is due on December 5 and despite inflation falling to a record low, swap markets …

Indian mutual funds pivot to ultra-short debt as rate outlook clouds bets Read More »

Softer dollar of scant help to rupee as importer hedging, outflows persist

13 Nov 2025

By Jaspreet Kalra MUMBAI (Reuters) -The Indian rupee closed marginally lower on Thursday as outflows and dollar demand spurred by persistent hedging from importers eclipsed the positive impulse from a broadly weaker dollar. The rupee closed at 88.6650 against the U.S. dollar, down slightly from its close at 88.63 in the previous session. Portfolio outflows …

Softer dollar of scant help to rupee as importer hedging, outflows persist Read More »

Speedo India licensee’s profit drops marginally on subdued demand

13 Nov 2025

(Reuters) -Page Industries, which licenses Jockey and Speedo brands in India, reported a marginal decline in quarterly profit on Thursday as consumers reined in spending, in part due to slow income growth. The apparel maker reported a profit of 1.948 billion rupees ($22.16 million) for the quarter ended September 30, down from 1.953 billion rupees …

Speedo India licensee’s profit drops marginally on subdued demand Read More »

Granules India posts higher quarterly profit on strong North America, Europe sales

13 Nov 2025

(Reuters) -Paracetamol maker Granules India reported a 34% jump in its second-quarter profit on Thursday, driven by strong demand in its key European and North American markets. Consolidated profit rose to 1.31 billion rupees (nearly $15 million) in the quarter ended September 30 from 972.3 million rupees a year earlier. Granules, which generates about two-thirds …

Granules India posts higher quarterly profit on strong North America, Europe sales Read More »

US proposal to halve biosimilar development costs for India’s Biocon, top exec says

13 Nov 2025

By Rishika Sadam (Reuters) -India’s Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday. Biosimilars are copies of costlier biological drugs used to treat major …

US proposal to halve biosimilar development costs for India’s Biocon, top exec says Read More »

Exclusive-Sweden’s Modern Times seeking $450 million IPO for India unit PlaySimple, sources say

13 Nov 2025

By Vibhuti Sharma MUMBAI (Reuters) -Swedish entertainment company Modern Times Group is planning to launch a $450 million initial public offering of its Indian game developer in Mumbai, two sources with direct knowledge of the matter said. Founded in 2014, Bengaluru-based PlaySimple offers mobile word games like the Daily Themed Crossword and Word Bingo, competing …

Exclusive-Sweden’s Modern Times seeking $450 million IPO for India unit PlaySimple, sources say Read More »

Exclusive-India markets regulator plans wide-ranging reforms to woo foreign investors, chief says

13 Nov 2025

By Jayshree P Upadhyay and Ira Dugal MUMBAI (Reuters) -India’s markets regulator is planning more reforms to woo foreign investors, including speeding up registration, reducing the cost of trading in the cash equities market and making it easier to short-sell, its chief said on Wednesday. Chairman Tuhin Kanta Pandey took over as head of the …

Exclusive-India markets regulator plans wide-ranging reforms to woo foreign investors, chief says Read More »

Close Bitnami banner
Bitnami